Source Search Page
endpts.com — 10+ hour, 32+ min ago
How Endpoints News will cover the future of the healthcare industry
endpts.com...I’m Lydia Ramsey Pflanzer, and for eight years, I’ve covered every part of the healthcare industry, diving deep into the changing way care... ...We’ll come to you a couple of times a week to start and more frequently as we get our feet under us.... ...ENDPOINTS MARKETING RX Tuesday at 2 PM ET ENDPOINTS FDA+ Wednesday at 2 PM ET ENDPOINTS MANUFACTURING Thursday at 2 PM ET ENDPOINTS WEEKLY Saturday...
endpts.com — 4+ hour, 30+ min ago
Gene therapy startup Lexeo files to go public in shrinking window for IPOs before Thanksgiving
endpts.com...A potential shutdown of the government would be one more hurdle for biotechs looking to get out, as the Securities and Exchange Commission... ...The New York-based biotech would join about a dozen other drug developers in going public this year, aiming to trade on the Nasdaq under... ...ENDPOINTS MARKETING RX Tuesday at 2 PM ET ENDPOINTS FDA+ Wednesday at 2 PM ET ENDPOINTS MANUFACTURING Thursday at 2 PM ET ENDPOINTS WEEKLY Saturday...
endpts.com — 6+ hour, 35+ min ago
GSK’s ViiV Healthcare set to launch second season of LGBTQ+ Latinx ‘telenovela-style’ podcast with celeb voices...
endpts.com...GSK’s ViiV is returning with a second season of its award-winning podcast “Love in Gravity.”... ...ENDPOINTS MARKETING RX Tuesday at 2 PM ET ENDPOINTS FDA+ Wednesday at 2 PM ET ENDPOINTS MANUFACTURING Thursday at 2 PM ET ENDPOINTS WEEKLY Saturday...
endpts.com — 6+ hour, 27+ min ago
FDA unveils new rare disease pilot program to increase agency-sponsor communications
endpts.com...The FDA on Friday unveiled new details around a rare disease pilot program that seeks to increase rapid, ad-hoc communications between... ...Between Jan. 2, 2024 and March 1, 2024, pilot program participants will be selected based on application readiness (e.g., sponsors who... ...ENDPOINTS MARKETING RX Tuesday at 2 PM ET ENDPOINTS FDA+ Wednesday at 2 PM ET ENDPOINTS MANUFACTURING Thursday at 2 PM ET ENDPOINTS WEEKLY Saturday...
endpts.com — 10+ hour, 19+ min ago
In the race to get type 1 patients off insulin, focus turns to cell transplants and insulin-producing stem cells...
endpts.com...Sernova’s treatment takes islets — the pancreatic cell group that includes beta cells, which are responsible for making insulin — from... ...In the race to get type 1 patients off insulin, focus turns to cell transplants and insulin-producing stem cells When Sernova announced... ...Led by former Trump official, Altesa BioSciences raises $35M for antivirals, recruits Moncef Slaoui to board Exclusive: Former Genentech... ...startup Thymmune lands $37M from Biden's ARPA-H for immune-rejuvenating therapies 5 Patient Engagement & Recruitment Trends, and...
endpts.com — 10+ hour, 8+ min ago
Madrigal raises $500M for NASH drug launch, discloses cyber attack
endpts.com...Madrigal Pharmaceuticals expects to raise $500 million from a stock and warrants sale, which it plans to use to prepare for the launch of... ...used for R&D work, clinical trial and manufacturing costs, and notably “potential acquisitions or licensing of new technologies,” Madrigal... ...ENDPOINTS MARKETING RX Tuesday at 2 PM ET ENDPOINTS FDA+ Wednesday at 2 PM ET ENDPOINTS MANUFACTURING Thursday at 2 PM ET ENDPOINTS WEEKLY Saturday...
endpts.com — 11+ hour, 38+ min ago
MEI Pharma pushes back on activist investors after failed merger with Infinity
endpts.com...The investors, Anson Advisors and Cable Car Capital, had tried buying the biotech earlier this year with an unsolicited bid, which MEI... ...soundly rejected in June as it was working on an all-stock merger with Infinity Pharmaceuticals.... ...ENDPOINTS MARKETING RX Tuesday at 2 PM ET ENDPOINTS FDA+ Wednesday at 2 PM ET ENDPOINTS MANUFACTURING Thursday at 2 PM ET ENDPOINTS WEEKLY Saturday...
endpts.com — 13+ hour, 58+ min ago
Scoop: Led by former Trump official, Altesa BioSciences raises $35M for antivirals, recruits Moncef Slaoui to board...
endpts.com...The College Park, GA-based startup is led by Brett Giroir, the former assistant secretary for health in the Department of Health and Human... ...Services during the Trump administration, acting FDA commissioner and admiral.... ...at 6 AM ET ENDPOINTS HEALTH TECH Coming soon... ...ENDPOINTS MARKETING RX Tuesday at 2 PM ET ENDPOINTS FDA+ Wednesday at 2 PM ET ENDPOINTS MANUFACTURING Thursday at 2 PM ET ENDPOINTS WEEKLY Saturday...
endpts.com — 14+ hour, 14+ min ago
Exclusive: Former Genentech duo reunites to push Sonoma into the clinic; Ex-Magenta commercial chief heads to Editas...
endpts.com...Then, Regeneron-partnered Sonoma Biotherapeutics came calling.... ...They’d go their separate ways a few years ago — Arron to 23andMe as chief scientific officer of its therapeutics push and Eisner to FibroGen... ...Arron had already been on Sonoma’s scientific advisory board, and now it was time to swap roles with science chief and co-founder Fred ... ...For Arron, the meeting sealed the deal -- he couldn't pass up the role if that meant working with an enthusiastic Eisner again....
endpts.com — 16+ hour, 40+ min ago
Stem cell startup Thymmune lands $37M from Biden's ARPA-H for immune-rejuvenating therapies
endpts.com...The Biden administration is awarding up to $37 million to Thymmune Therapeutics, the Advanced Research Projects Agency for Health (ARPA-H... ...Thymmune’s new funding comes amidst a busy week for ARPA-H, a new research agency that the Biden administration established last year to... ...at 6 AM ET ENDPOINTS HEALTH TECH Coming soon... ...ENDPOINTS MARKETING RX Tuesday at 2 PM ET ENDPOINTS FDA+ Wednesday at 2 PM ET ENDPOINTS MANUFACTURING Thursday at 2 PM ET ENDPOINTS WEEKLY Saturday...